Emily Y Chu

18PUBLICATIONS
61CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisPredictive and prognostic markersMolecular targetsToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 19, 2026
Eruptive Acral Melanocytic Lesions Associated With Capecitabine.

|Apr 29, 2026
Multicentric Asynchronous Endocrine Mucin-Producing Sweat Gland Carcinoma and Mucinous Carcinoma of the Skin.

|Oct 04, 2024
Evaluation and Surgical Management of Pediatric Cutaneous Melanoma and Atypical Spitz and Non-Spitz Melanocytic Tumors (Melanocytomas): A Report From Children's Oncology Group.

Michael R Sargen, Raymond L Barnhill, David E Elder

|Sep 17, 2024
Multiomics Profiling Distinguishes Sebaceous Carcinoma from Benign Sebaceous Neoplasms and Provides Insight into the Genetic Evolution of Sebaceous Carcinogenesis.

Gabriel J Starrett, Brittany C Baikie, Benjamin K Stoff

|Sep 07, 2022
The diverse landscape of dermatologic toxicities of non-immune checkpoint inhibitor monoclonal antibody-based cancer therapy.

Riyad N H Seervai, Sarah K Friske, Emily Y Chu

|Sep 02, 2022
Lichen-planus-pemphigoides-like reaction to PD-1 checkpoint blockade.

Margaret Wat, Nicholas K Mollanazar, Christoph T Ellebrecht

Pageof 3

Frequent Collaborators

2 joint publications

Michael R Sargen

2 joint publications

Jonathan L Curry

2 joint publications

Victor G Prieto

2 joint publications

Riyad N H Seervai